Vijaya Diagnost.
Vijaya Diagnost. Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
2 of 3 strong
The short version
Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets. Vijaya Diagnostic Centre delivered a strong Q1 FY27 with 23% revenue growth and is confident of high double-digit growth for the full year FY27.
From Vijaya Diagnost.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets.
- The company expects to sustain high double-digit revenue growth for FY27, building on a strong Q1 growth of 23%.
- Mid to long-term sustainable revenue growth is targeted around 15% annually over the next 3 to 5 years.
- Hyderabad cluster, which contributes ~67% of revenue, grew 17% year-on-year despite maturity, indicating strong organic growth.
- New tier-2 and metro locations like Rajahmundry, Tirupati, Kammam, Bangalore, Pune, and Kolkata are outperforming expectations, often breaking even within 2 quarters.
- Expansion focus includes dense networks in Pune, Bangalore, and Kolkata with plans to add 15 hubs across these metros over 12 months.
2 more points from Vijaya Diagnost.'s call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Vijaya Diagnost. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned capex of approximately INR 190 to 195 crores over the next 12 months.
- Commissioning of 9 new hub centres and 10 to 12 spoke centres; 2 hubs and 6 spokes already commissioned in the current year.
- Major capex includes INR 30 crores for a state-of-the-art hub facility in JP Nagar, Bangalore, featuring advanced imaging equipment and a central lab.
- Acquisition of land (~INR 8-10 crores) in a key medical hub in Andhra Pradesh to set up a new state-of-the-art hub centre due to unavailability of leased properties.
2 more points from Vijaya Diagnost.'s call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vijaya Diagnost. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Vijaya Diagnost.'s call on order book
Pro opens every point from 15K+ earnings calls
Vijaya Diagnost. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹219 Cr, net profit ₹48 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vijaya Diagnostic Centre Ltd's management said in earlier quarters
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Healthcare Services this season
- KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio DX Ltd (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
- Krsnaa Diagnostics Ltd (Q1 FY27)
. Key concall takeaways from Krsnaa Diagnost.'s Q1 FY27 earnings call — and how it ranks against sector peers.
- Artemis Medicare Services Ltd (Q1 FY27)
Potential to reach INR 2,000 crores topline from Gurgaon alone within 3-5 years. Key concall takeaways from Artemis Medicare Services Ltd's Q1 FY27 earnings…
Arthneeti Pro · Annual
Vijaya Diagnost. and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vijaya Diagnost. Q1 FY27 results?
Vijaya Diagnostic Centre plans to commission 9 new hub centres and 10-12 spoke centres in the upcoming year, continuing expansion in new markets. Vijaya Diagnostic Centre delivered a strong Q1 FY27 with 23% revenue growth and is confident of high double-digit growth for the full year FY27.
What is Vijaya Diagnost. share price analysis?
Vijaya Diagnost. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 82.6 with a market cap of ₹15,495 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vijaya Diagnost. planning capital expenditure?
Planned capex of approximately INR 190 to 195 crores over the next 12 months.
Keep Vijaya Diagnost. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.